期刊文献+

探讨炎症性肠病与肠道菌群 被引量:4

Inflammatory Bowel Disease and Intestinal Flora
下载PDF
导出
摘要 炎症性肠病是一种由肠道菌群与肠道免疫系统相互作用导致的慢性炎性疾病,通常受多种因素影响,多呈慢性、复发性或进行性炎症的病理表现,主要表现为肠道免疫反应和正常肠道菌群的改变,主要包括溃疡性结肠炎和Crohn病两种形式。目前关于炎症性肠病的病因和发病机制尚未明确,治疗方面也依然存在很多难点。众所周知,人体的肠道菌群是一个巨大的微生物生态系统,主要包括优势菌群、条件致病菌及病原菌三种类型,与人体正常机能的发挥关系密切,而肠道是机体最大的免疫器官,肠黏膜免疫系统是机体抵御肠腔内病原微生物入侵的第一道防线,已被公认为机体最重要的屏障之一,这两者可以通过复杂的交互作用来维持肠道内环境的稳态。该文将围绕肠道菌群、肠道免疫与炎症性肠病的相关性来探讨炎症性肠病的治疗策略。 Inflammatory bowel disease(IBD) is a chronic inflammatory disease caused by the interaction of intestinal flora and the intestinal immune system.It is usually affected by a variety of factors,most of which are chronic,recurrent or progressive inflammation.The pathological manifestations are mainly manifested as intestinal immune response and normal intestinal flora changes,mainly including ulcerative colitis(UC) and Crohn’s disease(CD) two forms.At present,the etiology and pathogenesis of inflammatory bowel disease are not clear,and there are still many difficulties in treatment.As we all know,the intestinal flora of the human body is a huge microbial ecosystem,mainly including three types of dominant bacteria,conditional pathogens and pathogenic bacteria,which are closely related to the normal function of the human body,and the intestine is the body’s largest immune organ.The intestinal mucosal immune system is the body’s first line of defense against the invasion of pathogenic microorganisms in the intestinal cavity.It has been recognized as one of the body’ s most important barriers.These two can maintain the steady state of the intestinal environment through complex interactions.This article discussed the treatment strategy of IBD around the correlation between intestinal flora,intestinal immunity and inflammatory bowel disease.
作者 李悦 刘肃志 张志君 梅祖兵 杨巍 LI Yue;LIU Suzhi;ZHANG Zhijun;MEI Zubing;YANG Wei(Anorectal Department,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处 《辽宁中医杂志》 CAS 2020年第6期49-52,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81673768,81774112)。
关键词 炎症性肠病 肠道菌群 肠道黏膜免疫 治疗 inflammatory bowel disease intestinal flora intestinal mucosal immunity treatment
  • 相关文献

参考文献3

二级参考文献55

  • 1张发明.“粪菌移植”治疗肠道病[J].祝您健康,2013(5):51-51. 被引量:2
  • 2Orna Nitzan,Mazen Elias,Bibiana Chazan,Raul Raz,Walid Saliba.Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment[J].World Journal of Gastroenterology,2013,19(43):7577-7585. 被引量:12
  • 3张静,韩英,王继恒,王志红.UC和其它肠道疾病肠道菌丛结构的ERIC-PCR指纹图谱分析[J].胃肠病学和肝病学杂志,2007,16(5):430-433. 被引量:13
  • 4Khor B, Gardet A, Xavier RJ. Genetics andpathogenesis of inflammatory bowel disease. Nature 2011; 474:307-317 [PMID: 21677747 DOI: 10.1038/nature10209]. 被引量:1
  • 5Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-429 [PMID: 12167685 DOI: 10.1056/NEJMra020831]. 被引量:1
  • 6Hooper LV, Gordon JI. Commensal host- bacterial relationships in the gut. Science 2001; 292:1115-1118 [PMID: 11352068 DOI: 10.1126/ science.1058709]. 被引量:1
  • 7Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004; 12: 129-134 [PMID: 15001189 DOI: 10.1016/j.tim.2004. 01.001]. 被引量:1
  • 8Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-1270 [PMID: 22424233 DOI: 10.1016/j.cell. 2012.01.035]. 被引量:1
  • 9Nugent SG, Kumar D, Rampton DS, Evans DF. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 2001; 48:571-577 [PMID: 11247905 DOI: 10.1136/gut.48.4.571]. 被引量:1
  • 10Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323 [PMID: 19343057 DOI: 10.1038/nri2515]. 被引量:1

共引文献55

同被引文献76

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部